Home/Filings/4/0001415889-22-008894
4//SEC Filing

Adler Reid G. 4

Accession 0001415889-22-008894

CIK 0001411685other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 3:45 PM ET

Size

5.2 KB

Accession

0001415889-22-008894

Insider Transaction Report

Form 4
Period: 2022-08-17
Adler Reid G.
Chief Legal Officer
Transactions
  • Purchase

    Common Stock

    2022-08-17$0.17/sh+300,000$50,910334,629 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1689 to $0.1701, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Issuer

VistaGen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1
  • filerCIK 0001924908

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 3:45 PM ET
Size
5.2 KB